Eptinezumab Safe, Effective for Migraine Prevention

Share this post

A single dose of eptinezumab, which targets calcitonin gene-related peptide, provides rapid efficacy lasting up to 3 months in the prevention of chronic migraine, say PROMISE-2 investigators.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply